ASP2151

Known as: ASP 2151 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2010-2016
02420102016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
We developed and validated bioanalytical methods for a potent helicase-primase inhibitor ASP2151 that has two conformers. These… (More)
Is this relevant?
2014
2014
Amenamevir is the international non-proprietary name for ASP2151 synthesized by Astellas Pharma, Inc. It is a structurally novel… (More)
Is this relevant?
2013
2013
ASP2151 (amenamevir) is a helicase-primase inhibitor against herpes simplex virus 1 (HSV-1), HSV-2, and varicella zoster virus… (More)
Is this relevant?
2013
2013
AIMS To determine the efficacy of a new helicase-primase inhibitor, ASP2151, for treating herpetic keratitis. METHODS Murine… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2012
2012
BACKGROUND Current therapies for genital herpes have only partial efficacy. Helicase-primase inhibitors are novel, potent… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2012
2012
ASP2151 is an antiherpes agent targeting the helicase-primase complex of herpes simplex virus (HSV)-1, HSV-2, and varicella… (More)
Is this relevant?
2012
2012
ASP2151 (amenamevir) is a helicase-primase inhibitor against herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
Is this relevant?
2012
2012
ASP2151 was developed as a novel inhibitor of herpes simplex virus (HSV) and varicella-zoster virus helicase-primase. The anti… (More)
Is this relevant?
2011
2011
ASP2151 is a herpesvirus helicase-primase inhibitor with antiviral activity against varicella zoster virus and herpes simplex… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 2
  • figure 3
Is this relevant?
2010
2010
OBJECTIVES To evaluate and describe the anti-herpesvirus effect of ASP2151, amenamevir, a novel non-nucleoside oxadiazolylphenyl… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?